The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors

被引:8
|
作者
Esposito, Gianluca [1 ]
Dell'Unto, Elisabetta [1 ]
Ligato, Irene [1 ]
Marasco, Matteo [1 ]
Panzuto, Francesco [1 ,2 ]
机构
[1] Sapienza Univ Rome, St andrea Univ Hosp, ENETS Ctr Excellence, Dept Med Surg Sci,Translat Med,Digest Dis Unit, Rome, Italy
[2] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Med Surg Sci & Translat Med, Via Grottarossa 1035, I-00189 Rome, Italy
关键词
endoscopy; neuroendocrine tumors; stomach; rectum; duodenum; tumor progression; residual disease; polypectomy; CARCINOID-TUMORS; MUCOSAL RESECTION; SUBMUCOSAL DISSECTION; TREATMENT OUTCOMES; CLINICAL-OUTCOMES; NON-AMPULLARY; RISK-FACTORS; FOLLOW-UP; MANAGEMENT; EFFICACY;
D O I
10.1080/17474124.2023.2242261
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionWell-differentiated gastric, duodenal, and rectal neuroendocrine neoplasms (NETs) are rare diseases usually managed by endoscopic treatment. Although several endoscopic techniques are available, the number of patients with incomplete (R1) resection is significant.Areas coveredThis review focuses on the meaning of incomplete R1 findings after endoscopic resection in type I gastric NETs; nonfunctioning, non-ampullary duodenal NETs; and small rectal NETs. Data were identified by MEDLINE database search without publication date limitation.Expert opinionAn incomplete R1 finding may have no significant impact on a patient's clinical outcome, particularly in small G1 type I gastric NETs, which have an indolent course. A 'stepwise approach,' which uses more advanced endoscopic techniques, or minimally invasive surgery may be justified to achieve complete margin-free resection. This approach must balance the tumor features and the procedure-related risk of complications, particularly in the duodenum, where the role of deep endoscopic resections is limited due to the thin duodenal wall. Gastric and rectal NETs that are incompletely removed after initial resection are more easily amenable to deep endoscopic techniques. However, this might not be necessary for patients with comorbidities, elderly, or both due to the uncertainty of how R1 finding impacts a patient's clinical outcome.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 50 条
  • [21] Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors
    Su Bum Park
    Hyung Wook Kim
    Dae Hwan Kang
    Cheol Woong Choi
    Su Jin Kim
    Hyeong Seok Nam
    World Journal of Gastroenterology, 2015, 21 (31) : 9387 - 9393
  • [22] R1 resection for gastric carcinoma
    Ridwelski, K.
    Fahlke, J.
    Huss, M.
    Otto, R.
    Wolff, S.
    CHIRURG, 2017, 88 (09): : 756 - 763
  • [23] Underwater Endoscopic Mucosal Resection of Small Rectal Neuroendocrine Tumors
    Okada, Masahiro
    Shinozaki, Satoshi
    Ikeda, Eriko
    Hayashi, Yoshikazu
    Takezawa, Takahito
    Fukuda, Hisashi
    Morikawa, Takaaki
    Kitamura, Masafumi
    Arita, Munefumi
    Nomura, Tatsuma
    Sakamoto, Hirotsugu
    Sunada, Keijiro
    Fukushima, Noriyoshi
    Lefor, Alan Kawarai
    Yamamoto, Hironori
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] Clinical outcomes of rectal neuroendocrine tumors treated by endoscopic resection
    Takita, Maiko
    Ohata, Ken
    Matsuhashi, Nobuyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 203 - 203
  • [25] Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors
    Park, Su Bum
    Kim, Hyung Wook
    Kang, Dae Hwan
    Choi, Cheol Woong
    Kim, Su Jin
    Nam, Hyeong Seok
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (31) : 9387 - 9393
  • [26] Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mm
    Rossi, Roberta Elisa
    Terrin, Maria
    Carrara, Silvia
    Maselli, Roberta
    Bertuzzi, Alexia Francesca
    Uccella, Silvia
    Lania, Andrea Gerardo Antonio
    Zerbi, Alessandro
    Hassan, Cesare
    Repici, Alessandro
    DIAGNOSTICS, 2024, 14 (14)
  • [27] ROLE OF ENDOSCOPIC RESECTION MARGIN (R1) IN THE CLINICAL OUTCOME OF PATIENTS WITH NEUROENDOCRINE NEOPLASIA
    Marasco, M.
    Massironi, S.
    Campana, D.
    Mosca, M.
    Dell'Unto, E.
    Pilozzi, E.
    Rinzivillo, M.
    Esposito, G.
    Annibale, B.
    Panzuto, F.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S169 - S169
  • [28] Role of endoscopic resection margin (R1) in the clinical outcome of patients with neuroendocrine neoplasia
    Marasco, M.
    Massironi, S.
    Campana, D.
    Mosca, M.
    Dell'unto, E.
    Pilozzi, E.
    Rinzivillo, M.
    Esposito, G.
    Annibale, B.
    Panzuto, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 164 - 164
  • [29] Endoscopic Resection for Rectal Neuroendocrine Tumors: Comparison of endoscopic mucosal resection, endoscopic submucosal resection with band ligation and endoscopic submucosal resection
    Shin, Y. W.
    Bang, B. W.
    Kwon, K. S.
    Jeong, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 20 - 20
  • [30] Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection
    Tran, Catherine G.
    Sherman, Scott K.
    Suraju, Mohammed O.
    Nayyar, Apoorve
    Gerke, Henning
    El Abiad, Rami G.
    Chandrasekharan, Chandrikha
    Ear, Po Hien
    O'Dorisio, Thomas M.
    Dillon, Joseph S.
    Bellizzi, Andrew M.
    Howe, James R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 75 - 84